Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov 6:10:8-12.
doi: 10.1016/j.ijcha.2015.11.002. eCollection 2016 Mar.

Predictors and outcome of no-reflow post primary percutaneous coronary intervention for ST elevation myocardial infarction

Jawad Mazhar  1 , Mary Mashicharan  1 , Ahmad Farshid  1   2
Affiliations

Predictors and outcome of no-reflow post primary percutaneous coronary intervention for ST elevation myocardial infarction

Jawad Mazhar et al. Int J Cardiol Heart Vasc. .

Abstract

Background: No-reflow (TIMI < 3) during primary PCI (PCI) for STEMI occurs in 11-41% of cases, indicates poor myocardial tissue perfusion, and is associated with a poor outcome. We aimed to determine predictors and 12 month outcomes of patients who developed no-reflow.

Methods: We analysed the PCI database of The Canberra Hospital and identified 781 patients who underwent primary PCI during 2008-2012. Follow-up at 12 months was with letter, phone call and review of hospital records.

Results: No-reflow was observed in 189 patients (25%) at the end of the procedure. Patients with no-reflow were older (64 vs. 61 years, p = 0.03). No-reflow patients were more likely to have initial TIMI flow < 3 (89% vs. 79%, p = 0.001), thrombus score ≥ 4 (83% vs. 69%, p = 0.0001), higher use of glycoprotein IIb/IIIa inhibitors (57% vs. 48%, p = 0.03) and longer median symptom to balloon time (223 min vs. 192 min, p = 0.004). No-reflow was an independent predictor of mortality (HR 1.95, CI 1.04-3.59, p = 0.037) during 12 month follow-up. On multivariate analysis, age > 60 years, thrombus score ≥ 4 and symptom to balloon time > 360 min were independent predictors of no-reflow. In 17% of cases of no reflow, it occurred only after stent insertion.

Conclusions: No-reflow occurred in 25% of STEMI patients undergoing primary PCI and was more likely with older age, high thrombus burden and delayed presentation. No-reflow was associated with a higher risk of death at 12 month follow-up.

Keywords: No-reflow; Primary percutaneous coronary intervention; ST elevation myocardial infarction; Slow coronary flow.

PubMed Disclaimer

References

    1. Steg P.G., James S.K., Atar D., Badano L.P., Blomstrom-Lundqvist C., Borger M.A. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur. Heart J. 2012;33(20):2569–2619. - PubMed
    1. Harrison R.W., Aggarwal A., Ou F.S., Klein L.W., Rumsfeld J.S., Roe M.T. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction. Am. J. Cardiol. 2013;111(2):178–184. - PubMed
    1. Schwartz B.G., Kloner R.A. Coronary no reflow. J. Mol. Cell. Cardiol. 2012;52(4):873–882. - PubMed
    1. Jaffe R., Dick A., Strauss B.H. Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach. JACC Cardiovasc. Interv. 2010;3(7):695–704. - PubMed
    1. Aung Naing K., Li L., Su Q., Wu T. Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction. Cochrane Database Syst. Rev. 2013;6:CD009503. - PubMed

LinkOut - more resources